Neurochemical Research

, Volume 38, Issue 8, pp 1580–1589

Glia Maturation Factor Expression in Hippocampus of Human Alzheimer’s Disease

Authors

  • Deirdre Stolmeier
    • Department of Neurology, Carver College of MedicineUniversity of Iowa Hospitals and Clinics
  • Ramasamy Thangavel
    • Department of Neurology, Carver College of MedicineUniversity of Iowa Hospitals and Clinics
    • Veterans Affair Health Care System
  • Poojya Anantharam
    • Department of Neurology, Carver College of MedicineUniversity of Iowa Hospitals and Clinics
  • Mohammad M. Khan
    • Department of Neurology, Carver College of MedicineUniversity of Iowa Hospitals and Clinics
  • Duraisamy Kempuraj
    • Department of Neurology, Carver College of MedicineUniversity of Iowa Hospitals and Clinics
    • Veterans Affair Health Care System
    • Department of Neurology, Carver College of MedicineUniversity of Iowa Hospitals and Clinics
    • Veterans Affair Health Care System
Original Paper

DOI: 10.1007/s11064-013-1059-3

Cite this article as:
Stolmeier, D., Thangavel, R., Anantharam, P. et al. Neurochem Res (2013) 38: 1580. doi:10.1007/s11064-013-1059-3
  • 318 Views

Abstract

Alzheimer’s disease (AD) is characterized by the presence of neuropathological lesions containing amyloid plaques (APs) and neurofibrillary tangles (NFTs) associated with neuroinflammation and neuronal degeneration. Hippocampus is one of the earliest and severely damaged areas in AD brain. Glia maturation factor (GMF), a known proinflammatory molecule is up-regulated in AD. Here, we have investigated the expression and distribution of GMF in relation to the distribution of APs and NFTs in the hippocampus of AD brains. Our immunohistochemical results showed GMF is expressed specifically in the vicinity of high density of APs and NFTs in the hippocampus of AD patients. Moreover, reactive astrocytes and activated microglia surrounds the APs and NFTs. We further demonstrate that GMF immunoreactive glial cells were increased at the sites of Tau containing NFTs and APs of hippocampus in AD brains. In conclusion, up-regulated expression of GMF in the hippocampus, and the co-localization of GMF and thioflavin-S stained NFTs and APs suggest that GMF may play important role in the pathogenesis of AD.

Keywords

Alzheimer’s diseaseAmyloid plaquesGlial fibrillary acidic proteinGlia maturation factorHippocampusIonized calcium binding adaptor molecule 1

Copyright information

© Springer Science+Business Media New York 2013